northfield
laboratories
said
wednesday
received
clearance
food
drug
administration
begin
phase
iii
trials
company
blood
substitute
polyheme.surgical
patients
infused
units
polyheme
trials
northfield
said.the
randomized
controlled
study
include
250
elective
surgery
patients
expected
12
months
northfield
said
unit
level
represents
60
percent
adult
entire
blood
volume
northfield
said
northfield
firm
report
successful
achievement
high
dose
limit
phase
clinical
testing
firm
evaluate
oxygen
carrier
direct
replacement
blood
high
volumes
phase
iii
study
said
development
stage
company
chicago
newsdesk
312-408-8787
